Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-08-07 Greenleaf Peter Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2019-05-24 Greenleaf Peter Director Returned to the company −300,000 112,500
2019-05-24 Greenleaf Peter Director Returned to the company · Employee Stock Option (Right to Buy) +325,000 0
2019-05-24 Greenleaf Peter Director Returned to the company · Employee Stock Option (Right to Buy) +364,583 135,417
2019-05-24 Greenleaf Peter Director Returned to the company · Employee Stock Option (Right to Buy) +500,000 0
2019-04-01 Greenleaf Peter Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +325,000 325,000
2018-05-18 Greenleaf Peter Chief Executive Officer Purchase +12,500 $3.98 $50K 412,500
2018-03-27 Greenleaf Peter Chief Executive Officer Grant or award +400,000 400,000
2018-03-27 Greenleaf Peter Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +500,000 500,000
2018-03-27 Greenleaf Peter Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +500,000 500,000

Page 1 of 1 · 10 trades